Iron metabolism and iron supplementation in cancer patients
Heinz Ludwig(Wilhelminen Hospital), Hartmut Link(Medizinische Hochschule Hannover), Houman Kamali(Bristol-Myers Squibb (Germany)), Alois Lang(Landeskrankenhaus Feldkirch), Thomas Bauernhofer, Heinz Gisslinger(Medical University of Vienna), Holger Rumpold(Innsbruck Medical University), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Elisabeth Koller(Hanusch Hospital), Michael Steurer(Innsbruck Medical University), Michael Fridrik, Rayko Evstatiev(Medical University of Vienna), Klaus Geißler(University of Vienna), Gabriela Kornek(Medical University of Vienna), Gerhard Kopetzky(Universitätsklinikum St. Pölten), D. Geißler(Klinikum Klagenfurt), Matti Aapro(Clinique de Genolier)
Cited by 161
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k